Samarium 153-labeled hydroxyapatite microspheres for radiation synovectomy in the horse: a study of the biokinetics, dosimetry, clinical, and morphologic response in normal metacarpophalangeal and metatarsophalangeal joints.
Authors: Yarbrough T B, Lee M R, Hornof W J, Koblik P D, Brodack J, Troup C, O'Brien T R, Pool R
Journal: Veterinary surgery : VS
Summary
# Editorial Summary: Samarium-153 Radiation Synovectomy in Equine Metacarpophalangeal and Metatarsophalangeal Joints Radiation synovectomy using intra-articular radiopharmaceuticals offers an alternative approach to managing chronic synovitis in high-motion joints, and this 2000 study evaluated the safety and efficacy of samarium-153–labelled hydroxyapatite microspheres (153SmM) in equine pastern and fetlock joints. Twelve clinically normal horses received intra-articular injections across three dose groups (3.5–17.0 mCi), with contralateral joints serving as controls; animals were monitored clinically for 7 days post-injection and then sequentially euthanatised at 14, 30, and 60 days for histopathological examination of synovial and cartilaginous tissues. The treatment reliably produced synovitis with transient lameness, effusion, and regional oedema lasting 48–72 hours, with minimal systemic absorption (well below the 1 mCi tolerance threshold in blood and urine), and crucially, caused no microscopic damage to articular cartilage. Synovectomy was histologically achieved but incomplete, with some areas of necrosis extending into subintimal regions and occasional islands of viable intimal cells remaining. For practitioners managing chronic inflammatory joint disease refractory to conventional therapies, this research demonstrates that 153SmM intra-articular injection can selectively target and ablate synovial tissue in weight-bearing joints without cartilage compromise or significant extracapsular leakage, though the incomplete synovectomy suggests clinical efficacy may depend on the extent of synovial involvement and degree of inflammation present.
Read the full abstract on PubMed
Practical Takeaways
- •Radiation synovectomy with Samarium-153 microspheres may offer a targeted approach to managing chronic synovitis in fetlock joints with minimal systemic toxicity, though clinical efficacy in naturally-occurring disease remains to be demonstrated
- •Expect transient lameness and joint swelling for 2-3 days post-injection; this is an expected inflammatory response, not a complication
- •The intermediate dose range (6.5-12.0 mCi) may be preferred to balance synovectomy effectiveness with safety profile, but optimal therapeutic dosing for clinical disease requires further study
Key Findings
- •Intraarticular Samarium-153 hydroxyapatite microspheres caused transient inflammation (lameness, effusion, edema) lasting 48-72 hours with dose-dependent response across three dose levels (3.5-17.0 mCi)
- •Minimal systemic absorption occurred with blood and urine levels well below 1 mCi safety threshold, indicating effective joint containment
- •Microscopic examination showed effective synovectomy of intimal cells with no cartilage damage but incomplete synovial membrane destruction (some intact intimal islands persisted)
- •Treatment was well-tolerated with no long-term complications observed through 60 days post-injection across all three dose groups